New patent expiration for Alexza Pharms drug ADASUVE
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. […]
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. […]
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
ADASUVE (loxapine) Alexza pharms Patent: 9,370,629 Expiration: May 20, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of May 19, 2024 Read Post »
Annual Drug Patent Expirations for EQUETRO Equetro is a drug marketed by Validus Pharms and is included in one NDA.
New patent expiration for Validus Pharms drug EQUETRO Read Post »
Annual Drug Patent Expirations for ULESFIA Ulesfia is a drug marketed by Shionogi Inc and is included in one NDA.
New patent expiration for Shionogi Inc drug ULESFIA Read Post »
ADASUVE (loxapine) Alexza pharms Patent: 9,370,629 Expiration: May 20, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of May 19, 2024 Read Post »
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
Annual Drug Patent Expirations for NYMALIZE Nymalize is a drug marketed by Azurity and is included in one NDA. It
Annual Drug Patent Expirations for ALIQOPA Aliqopa is a drug marketed by Bayer Healthcare and is included in one NDA.
New patent expiration for Bayer Healthcare drug ALIQOPA Read Post »
Get fresh news and insights, drug patent expirations & more…